Create Alert
Watchlist

Aarti Drugs

₹394.80
+5.20 (1.33%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
390.00
Prev. Close
389.60
Volume
94,121
Total traded value
3.72 Cr
Upper Circuit
467.50
Lower Circuit
311.70

Fundamentals

Market Cap₹3,561Cr
ROE13.56%
P/E Ratio(TTM)17.90
EPS(TTM)21.80
P/B Ratio2.43
Dividend Yield0.26%
Industry P/E32.95
Book Value160.87
Debt to Equity0.39
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Aarti Drugs

Established in 1984, Aarti Drugs Limited is a prominent player in the pharmaceutical industry, well-positioned for future market growth. Its vision is to become the first-choice vendor for bulk drugs by providing customized solutions and services to meet the changing requirements of customers. The company's mission is to seek global market leadership and strive for excellence in customer service, quality, and R&D. It specializes in manufacturing active pharmaceutical ingredients (APIs), specialty chemicals, and intermediates across various therapeutic categories like antibiotics and anti-diabetics. Through its wholly-owned subsidiary, Pinnacle Life Sciences Private Limited, the company also manufactures advanced formulations, playing a pivotal role in its revenue generation. Aarti Drugs is one of the world's leading producers of Metformin and the largest producer of Metronidazole in India, showcasing its market leadership.;
Parent OrganisationAarti Drugs Limited
Managing DirectorShri Prakash M. Patil
Founded1984
NSE SymbolAARTIDRUGS

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
54.72%
Retail And Others
32.69%
Mutual Funds
9.81%
Foreign Institutions
2.69%
Other Domestic Institutions
0.09%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Divi's Laboratories
NA
(0.00%)
67.22
Neuland Laboratories
NA
(0.00%)
87.06
Jubilant Pharmova
NA
(0.00%)
35.59
Acutaas Chemicals
NA
(0.00%)
61.09
2025
7
Nov
Quarterly Result
Release date
18
Jul
Quarterly & Annual Result
Release date
6
May
Quarterly & Annual Result
Release date

4
Feb
Dividend
Ex date
₹1.00
per share

For each share you hold, you will receive ₹1.00
Dividend amount₹1.00 per share
Dividend TypeInterim
Ex Date4 Feb ‘25
Record Date4 Feb ‘25
Announcement date29 Jan ‘25

29
Jan
Dividend
Announced
₹1.00
per share

For each share you hold, you will receive ₹1.00
Dividend amount₹1.00 per share
Dividend TypeInterim
Ex Date4 Feb ‘25
Record Date4 Feb ‘25
Announcement date29 Jan ‘25
29
Jan
Quarterly & Annual Result
Release date
2024
24
Oct
Quarterly Result
Release date

5
Sep
Buyback
Ex date

Offer price₹900.00
Buyback window11 Sep ‘24 to 19 Sep ‘24
Ex date5 Sep ‘24
Record date5 Sep ‘24
Announcement date26 Aug ‘24
Buyback typeTender Offer

26
Aug
Buyback
Announced

Offer price₹900.00
Buyback window11 Sep ‘24 to 19 Sep ‘24
Ex date5 Sep ‘24
Record date5 Sep ‘24
Announcement date26 Aug ‘24
Buyback typeTender Offer
26
Jul
Quarterly & Annual Result
Release date

6
Feb
Dividend
Ex date
₹1.00
per share

For each share you hold, you will receive ₹1.00
Dividend amount₹1.00 per share
Dividend TypeInterim
Ex Date6 Feb ‘24
Record Date6 Feb ‘24
Announcement date24 Jan ‘24

24
Jan
Dividend
Announced
₹1.00
per share

For each share you hold, you will receive ₹1.00
Dividend amount₹1.00 per share
Dividend TypeInterim
Ex Date6 Feb ‘24
Record Date6 Feb ‘24
Announcement date24 Jan ‘24
Events calendar
View upcoming events in other stocks